Ansell Limited (ANSLY)
USD 85.32
(0.0%)
USD 85.32
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 76.5 Million USD | -48.42% |
| 2023 | 148.3 Million USD | -6.55% |
| 2022 | 158.7 Million USD | -35.67% |
| 2021 | 246.7 Million USD | 55.45% |
| 2020 | 158.7 Million USD | 42.08% |
| 2019 | 111.7 Million USD | -19.47% |
| 2018 | 138.7 Million USD | 16.85% |
| 2017 | 118.7 Million USD | -13.48% |
| 2016 | 137.2 Million USD | -26.83% |
| 2015 | 187.5 Million USD | 348.56% |
| 2014 | 41.8 Million USD | -69.97% |
| 2013 | 139.2 Million USD | 4.63% |
| 2012 | 133.04 Million USD | 1.45% |
| 2011 | 131.13 Million USD | 29.23% |
| 2010 | 101.47 Million USD | 29.55% |
| 2009 | 78.32 Million USD | -20.21% |
| 2008 | 98.16 Million USD | 15.73% |
| 2007 | 84.81 Million USD | 33.39% |
| 2006 | 63.58 Million USD | 6217.87% |
| 2005 | -1.03 Million USD | -11.19% |
| 2004 | -934.75 Thousand USD | 21.41% |
| 2003 | -1.18 Million USD | -33.66% |
| 2002 | -889.87 Thousand USD | 5.77% |
| 2001 | -944.33 Thousand USD | 35.72% |
| 2000 | -1.46 Million USD | 41.94% |
| 1999 | -2.53 Million USD | -760.38% |
| 1998 | 383.15 Thousand USD | 109.58% |
| 1997 | -3.99 Million USD | -3.48% |
| 1996 | -3.86 Million USD | 15.37% |
| 1995 | -4.56 Million USD | -70.39% |
| 1994 | -2.68 Million USD | -2.36% |
| 1993 | -2.61 Million USD | 85.34% |
| 1992 | -17.86 Million USD | -25.87% |
| 1991 | -14.19 Million USD | 63.79% |
| 1990 | -39.2 Million USD | 81.46% |
| 1989 | -211.49 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 76.5 Million USD | -48.42% |
| 2024 Q4 | 56.85 Million USD | 0.0% |
| 2024 Q3 | 28.55 Million USD | 194.33% |
| 2024 Q2 | 9.7 Million USD | 0.0% |
| 2024 Q1 | 9.7 Million USD | -77.01% |
| 2023 FY | 148.3 Million USD | -6.55% |
| 2023 Q1 | 31.95 Million USD | -21.6% |
| 2023 Q2 | 31.95 Million USD | 0.0% |
| 2023 Q3 | 42.2 Million USD | 32.08% |
| 2023 Q4 | 42.2 Million USD | 0.0% |
| 2022 FY | 158.7 Million USD | -35.67% |
| 2022 Q4 | 40.75 Million USD | 0.0% |
| 2022 Q2 | 38.6 Million USD | 0.0% |
| 2021 Q4 | 70.4 Million USD | 0.0% |
| 2021 FY | 246.7 Million USD | 55.45% |
| 2021 Q2 | 52.95 Million USD | 0.0% |
| 2020 Q2 | 32.9 Million USD | 0.0% |
| 2020 Q4 | 45.4 Million USD | 0.0% |
| 2020 FY | 158.7 Million USD | 42.08% |
| 2019 Q4 | 36.1 Million USD | 0.0% |
| 2019 FY | 111.7 Million USD | -19.47% |
| 2019 Q2 | 19.75 Million USD | 0.0% |
| 2018 Q2 | 33.2 Million USD | 0.0% |
| 2018 FY | 138.7 Million USD | 16.85% |
| 2018 Q4 | 36.15 Million USD | 0.0% |
| 2017 Q2 | 26.7 Million USD | 0.0% |
| 2017 FY | 118.7 Million USD | -13.48% |
| 2017 Q4 | 32.65 Million USD | 0.0% |
| 2016 Q2 | 34.8 Million USD | 0.0% |
| 2016 Q4 | 22.85 Million USD | 0.0% |
| 2016 FY | 137.2 Million USD | -26.83% |
| 2015 Q4 | 49.9 Million USD | 0.0% |
| 2015 Q2 | 43.85 Million USD | 0.0% |
| 2015 FY | 187.5 Million USD | 348.56% |
| 2014 Q1 | 32.79 Million USD | -20.1% |
| 2014 Q2 | 32.79 Million USD | 0.0% |
| 2014 Q3 | -11.9 Million USD | -136.28% |
| 2014 FY | 41.8 Million USD | -69.97% |
| 2014 Q4 | -11.9 Million USD | 0.0% |
| 2013 Q4 | 41.05 Million USD | 0.0% |
| 2013 FY | 139.2 Million USD | 4.63% |
| 2013 Q1 | 33.78 Million USD | 0.0% |
| 2013 Q2 | 35.67 Million USD | 5.58% |
| 2013 Q3 | 41.05 Million USD | 15.06% |
| 2012 Q2 | 34.78 Million USD | 16.43% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | 133.04 Million USD | 1.45% |
| 2012 Q1 | 29.87 Million USD | 0.0% |
| 2012 Q3 | 33.77 Million USD | -2.9% |
| 2011 Q1 | 28.9 Million USD | 0.0% |
| 2011 FY | 131.13 Million USD | 29.23% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 31.71 Million USD | 3.95% |
| 2011 Q2 | 30.5 Million USD | 5.55% |
| 2010 FY | 101.47 Million USD | 29.55% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 27.44 Million USD | 3.18% |
| 2010 Q1 | 26.45 Million USD | 0.0% |
| 2010 Q2 | 26.59 Million USD | 0.55% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | 78.32 Million USD | -20.21% |
| 2009 Q1 | 19.77 Million USD | 0.0% |
| 2009 Q2 | 19.64 Million USD | -0.63% |
| 2009 Q3 | 21.49 Million USD | 9.4% |
| 2008 FY | 98.16 Million USD | 15.73% |
| 2008 Q3 | 23.52 Million USD | 2.02% |
| 2008 Q2 | 23.06 Million USD | 4.49% |
| 2008 Q1 | 22.07 Million USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q1 | 21.72 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 20.23 Million USD | 4.45% |
| 2007 Q2 | 19.36 Million USD | -10.86% |
| 2007 FY | 84.81 Million USD | 33.39% |
| 2006 FY | 63.58 Million USD | 6217.87% |
| 2006 Q1 | -341.99 Thousand USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | 21.79 Million USD | 6472.43% |
| 2006 Q3 | 20.64 Million USD | -5.26% |
| 2005 Q1 | -342.92 Thousand USD | 0.0% |
| 2005 FY | -1.03 Million USD | -11.19% |
| 2005 Q2 | -348.05 Thousand USD | -1.5% |
| 2005 Q4 | - USD | 100.0% |
| 2005 Q3 | -346.7 Thousand USD | 0.39% |
| 2004 FY | -934.75 Thousand USD | 21.41% |
| 2004 Q2 | -364.1 Thousand USD | 17.95% |
| 2004 Q1 | -443.76 Thousand USD | 0.0% |
| 2004 Q4 | - USD | 100.0% |
| 2004 Q3 | -360.73 Thousand USD | 0.93% |
| 2003 FY | -1.18 Million USD | -33.66% |
| 2003 Q2 | -381.91 Thousand USD | -0.29% |
| 2003 Q1 | -380.8 Thousand USD | 0.0% |
| 2003 Q4 | - USD | 100.0% |
| 2003 Q3 | -390.15 Thousand USD | -2.16% |
| 2002 Q4 | - USD | 100.0% |
| 2002 Q3 | -371.79 Thousand USD | -4.45% |
| 2002 FY | -889.87 Thousand USD | 5.77% |
| 2002 Q1 | -442.9 Thousand USD | 0.0% |
| 2002 Q2 | -355.95 Thousand USD | 19.63% |
| 2001 Q1 | -560.44 Thousand USD | 0.0% |
| 2001 FY | -944.33 Thousand USD | 35.72% |
| 2001 Q4 | - USD | 100.0% |
| 2001 Q3 | -441.16 Thousand USD | 10.97% |
| 2001 Q2 | -495.54 Thousand USD | 11.58% |
| 2000 FY | -1.46 Million USD | 41.94% |
| 2000 Q1 | -934.42 Thousand USD | 0.0% |
| 2000 Q3 | -626.41 Thousand USD | 5.61% |
| 2000 Q2 | -663.64 Thousand USD | 28.98% |
| 2000 Q4 | - USD | 100.0% |
| 1999 Q4 | - USD | 100.0% |
| 1999 FY | -2.53 Million USD | -760.38% |
| 1999 Q3 | -900.62 Thousand USD | -0.27% |
| 1999 Q1 | 148.67 Thousand USD | 0.0% |
| 1999 Q2 | -898.23 Thousand USD | -704.18% |
| 1998 Q4 | - USD | -100.0% |
| 1998 FY | 383.15 Thousand USD | 109.58% |
| 1998 Q3 | 164.48 Thousand USD | -3.21% |
| 1998 Q1 | -1.28 Million USD | 0.0% |
| 1998 Q2 | 169.94 Thousand USD | 113.22% |
| 1997 Q4 | - USD | 100.0% |
| 1997 Q3 | -1.38 Million USD | -2.31% |
| 1997 Q1 | -1.22 Million USD | -0.2% |
| 1997 FY | -3.99 Million USD | -3.48% |
| 1997 Q2 | -1.35 Million USD | -10.37% |
| 1996 Q1 | -1.69 Million USD | -5.73% |
| 1996 FY | -3.86 Million USD | 15.37% |
| 1996 Q2 | -1.16 Million USD | 31.34% |
| 1996 Q3 | -1.21 Million USD | -4.06% |
| 1996 Q4 | -1.22 Million USD | -1.03% |
| 1995 Q3 | -1.64 Million USD | 3.37% |
| 1995 Q4 | -1.6 Million USD | 2.34% |
| 1995 FY | -4.56 Million USD | -70.39% |
| 1995 Q1 | -931.52 Thousand USD | -1.58% |
| 1995 Q2 | -1.7 Million USD | -82.87% |
| 1994 Q1 | -944.99 Thousand USD | 3.57% |
| 1994 FY | -2.68 Million USD | -2.36% |
| 1994 Q4 | -917.01 Thousand USD | -3.49% |
| 1994 Q2 | -893.23 Thousand USD | 5.48% |
| 1994 Q3 | -886.13 Thousand USD | 0.8% |
| 1993 Q3 | -1.02 Million USD | -3.72% |
| 1993 Q4 | -979.94 Thousand USD | 4.5% |
| 1993 FY | -2.61 Million USD | 85.34% |
| 1993 Q2 | -989.29 Thousand USD | 82.79% |
| 1993 Q1 | -5.74 Million USD | 3.88% |
| 1992 Q4 | -5.97 Million USD | 2.8% |
| 1992 FY | -17.86 Million USD | -25.87% |
| 1992 Q1 | -4.8 Million USD | -3.93% |
| 1992 Q2 | -6 Million USD | -24.82% |
| 1992 Q3 | -6.15 Million USD | -2.49% |
| 1991 Q3 | -4.67 Million USD | 1.11% |
| 1991 Q4 | -4.62 Million USD | 0.99% |
| 1991 Q2 | -4.72 Million USD | 63.53% |
| 1991 FY | -14.19 Million USD | 63.79% |
| 1991 Q1 | -12.95 Million USD | -4.87% |
| 1990 Q1 | -71.78 Million USD | -2.5% |
| 1990 Q2 | -12.04 Million USD | 83.21% |
| 1990 Q3 | -11.76 Million USD | 2.34% |
| 1990 Q4 | -12.35 Million USD | -5.0% |
| 1990 FY | -39.2 Million USD | 81.46% |
| 1989 Q2 | -81.6 Million USD | 0.0% |
| 1989 FY | -211.49 Million USD | 0.0% |
| 1989 Q4 | -70.03 Million USD | 7.21% |
| 1989 Q3 | -75.47 Million USD | 7.51% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 8353.38% |
| Ansell Limited | 76.5 Million USD | 0.0% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -215.072% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 4792.552% |
| Psykey, Inc. | -1.32 Million USD | 5878.159% |
| ConvaTec Group Plc | 130.3 Million USD | 41.289% |
| ConvaTec Group Plc | 130.3 Million USD | 41.289% |
| Encision Inc. | -691.78 Thousand USD | 11158.381% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 54045.04% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 32741.253% |
| Innovative MedTech Inc. | -7.93 Million USD | 1063.61% |
| LifePoint, Inc. | -15.23 Million USD | 602.245% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 1223.183% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 16239.241% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 27974.336% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 16765.65% |
| SmileDirectClub, Inc. | -86.4 Million USD | 188.538% |
| Sector 10, Inc. | 7036.00 USD | -1087165.492% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 96.179% |
| SheerVision, Inc. | -71.37 Thousand USD | 107278.884% |
| United Health Products, Inc. | -2.62 Million USD | 3016.211% |
| Vasamed, Inc. | -4.88 Million USD | 1665.008% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 3302.891% |
| Yubo International Biotech Limited | -1.2 Million USD | 6449.786% |